MARINE BIOTECHNOLOGY - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Marine Biotechnology in US$ Million. The Global market is further analyzed by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. Major End-Use Applications also analyzed for the global market include Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 99 companies including many key and niche players such as -

Aker BioMarine AS
Aqua Bio Technology ASA
Aquapharm Biodiscovery Ltd.
CP Kelco
Cyanotech Corp.
Nutrex Hawaii


Click here to request a full list of companies covered in the report...

Code : MCP-1612
Price : $4950
Companies : 99
Pages : 245
Date : November 2013
Market Data Tables : 24
Status: * New Report

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   A Quick Primer.....II-11$100
   Marine Biotechnology: A Science to Address Global Challenges.....II-2
Current and Future Analysis.....II-2
2$200
   Economic Uncertainty Affects Marine Biotechnology Market.....II-41$100
   Biotechnology Market: Uncertain Economy Hits R&D Funding.....II-5
Noteworthy Trends & Issues.....II-5
Medical, Food and Cosmetic Sectors Garner Research Dollars.....II-5
1$100
   Health-Promoting Benefits of Marine Algal Proteins.....II-6
Sea Anemone Toxins: Opportunities for Pharma & Agricultural Sectors.....II-6
Marine Worm: Potential Role in Medical Applications.....II-6
1$100
   Coral Reefs Offer Abundant Opportunities.....II-7
Marine Microalgae: Promising Potential in Varied Industries.....II-7
1$100
   Commercially Cultivated Marine Microalgae Species and their Applications.....II-8
Major Applications of Marine Microalgae Biomass or their Extracts.....II-8
1$100
   Polysaccharides from Marine Microalgae Holds Tremendous Potential.....II-9
Select Marine Microalgae Species Producing Polysaccharides.....II-9
1$100
   Carotenoids of Marine Origin: Key Applications.....II-10
Major Commercially Available Carotenoids.....II-10
1$100
   Rising Demand for HVAB’s: Threat to Marine Biodiversity?.....II-11
Marine Ingredients for Bonding Applications: A Research Focus.....II-11
Biopharmaceutical Companies Shift towards Marine Natural Products.....II-11
1$100
   Technology Advancements Aid Research Activities.....II-12
Partnerships: Vital for Development of Marine Biotechnology Research.....II-12
2$200
   Megaprojects Hold Significance for Marine Biotechnology Development.....II-14
Lack of R&D Investment in Marine Biotech: A Challenge.....II-14
1$100
   Preserving Marine Ecology: A Prime Concern.....II-151$100
   Marine Biotechnology for Sustainable Production of Healthy Food Products.....II-16
Table 1: World Fisheries & Aquaculture Market (2011): Breakdown of Production (in Million Tonnes) by Capture Fisheries and Aquaculture (includes corresponding Graph/Chart).....II-16
1$350
   Table 2: World Fisheries & Aquaculture Market (2011): Breakdown of Production (in Million Tonnes) by Human Consumption and Non-Food Uses (includes corresponding Graph/Chart).....II-17
Marine Resources as Functional Food Ingredients.....II-17
2$350
   Health Benefits of Few Marine-derived Functional Food Ingredients.....II-19
Marine-Derived Nutraceuticals.....II-19
1$100
   Major Marine Nutraceutical Products: A Glance.....II-201$100
   Global Omega-3 Ingredients Market – A Review.....II-21
Table 3: World Omega-3 Dietary Supplements Market (2012): Percentage Share Breakdown of Volume Sales by Geographic Region - North America, Europe, Asia-Pacific, and Rest of World (includes corresponding Graph/Chart).....II-21
1$350
   Marine Biotechnology for Energy Supply.....II-221$100
   Feasibility of Using Algae for Biofuel Production.....II-23
Marine Organisms in Cosmetics Industry.....II-23
Marine Ingredients in Cosmetics Industry.....II-23
1$100
   Cosmetics Industry: Focus Shifts to Sustainable Sourcing of Marine
  Ingredients.....II-24
1$100
   Marine Biotechnology for Industrial Processing.....II-25
Marine Microbial Enzymes.....II-25
1$100
   Marine-Derived Biopolymers & Biomaterials.....II-261$100
   Marine Micro & Macro Algae.....II-27
Chitin & Chitosan.....II-27
1$100
   Marine Bacteria.....II-28
Bioceramics.....II-28
Extremozymes.....II-28
1$100
   Marine Biotechnology for Protecting Marine Ecosystems.....II-29
Biofouling.....II-29
1$100
   Detecting Marine Pathogenic Organisms.....II-30
Bioremediation of Marine Ecosystems.....II-30
Marine Coatings Market.....II-30
1$100
   Marine-Derived Pharmaceuticals.....II-31
Brief History.....II-31
Major Marine Sources for Drugs.....II-31
1$100
   Applications of Marine Products in Pharmaceutical Industry.....II-321$100
   Invertebrates – Major Focus of Research.....II-33
Marine Flora – Largely Unexplored.....II-33
Research Focus Entrenched on Marine Drugs.....II-33
2$200
   FDA-Approved Marine Medicines by Therapeutic Category.....II-35
Robust Clinical Pipeline to Support Growth.....II-35
1$100
   Select Marine-Derived Compounds in Phase I, II, III Clinical Trials.....II-36
Anti-Cancer Drugs Dominate Drug Development Pipeline.....II-36
1$100
   Anti-Cancer Marine Drugs in Clinical Trials.....II-371$100
   Overview of FDA-Approved Anti-Tumor Drugs of Marine Origin.....II-38
PharmaMar: Undisputed Leader in Oncology Medicines of Marine Origin.....II-38
1$100
   PharmaMar’s Clinical Pipeline of Marine-based Anti-Tumor Drugs.....II-39
Cardiovascular Marine Products.....II-39
Cardiovascular Marine Products by Marine Source.....II-39
An Overview of Select Cardiovascular Marine Products.....II-39
1$100
   Key Challenges in Discovery of Marine-derived Drugs.....II-401$100
   Overview.....II-411$100
   R&D Initiatives, Funding Programs & Research Priorities for Marine
  Biotechnology.....II-42
The United States.....II-42
1$100
   Canada.....II-43
Japan.....II-43
Europe.....II-43
1$100
   Turkey.....II-44
Asia.....II-44
Australia & New Zealand.....II-44
1$100
   China.....II-45
India.....II-45
South Korea.....II-45
Southeast Asia.....II-45
1$100
   Latin America.....II-46
Middle East & Africa.....II-46
International Efforts in Marine Biotechnology Research.....II-46
1$100
   Major R&D Projects in Marine Biotechnology Space.....II-47
EU Embarks on Ground-Breaking Marine Plankton Project.....II-47
KIOST Augments Research on Marine Biotechnology.....II-47
EU Launches BlueGenics Research Project.....II-47
1$100
   Smithsonian Tropical Research Institute to Launch Global Marine Biodiversity
  Project.....II-48
1$100
   Prelude.....II-49
Significance of Marine Biodiversity.....II-49
1$100
   Marine Biotechnology: Definition.....II-50
Why are Marine Organisms Crucial?.....II-50
1$100
   Sources of Marine Biotech Products.....II-51
Key Marine Sources and Products.....II-51
1$100
   Select Marine-Derived Products.....II-52
Marine Sponges.....II-52
Marine Plants.....II-52
1$100
   Protista.....II-53
Marine Bacteria.....II-53
Marine Fungi.....II-53
Types of Marine Biotech Products.....II-53
Marine Biomaterials.....II-53
Marine Adhesives.....II-53
1$100
   Marine Bioactive Substances.....II-54
Enzymes.....II-54
Haloperoxidase Enzymes.....II-54
Thermostable DNA-Modifying Enzymes.....II-54
1$100
   Other Marine Products and Processes.....II-55
Marine Biomass.....II-55
Marine Bio-Process.....II-55
Significant Bio-Processes and their Applications.....II-55
End-Use Analysis.....II-55
1$100
   Foods.....II-561$100
   Nutraceuticals.....II-57
Medicine.....II-57
Cosmetics.....II-57
Research Tools.....II-57
1$100
   Processing Technologies.....II-58
New Energy Sources.....II-58
Agriculture.....II-58
Industrial.....II-58
1$100
   Food Safety.....II-59
Environmental Management.....II-59
Bioremediation.....II-59
Marine Biosurfactants.....II-59
1$100
   Select Biosurfactants Produced from Marine Microorganisms.....II-60
Aquaculture and Marine Biotechnology.....II-60
1$100
   Select Companies Carrying Out Genetic Enhancement or Aquaculture Breeding
  Programs.....II-61
Industrial Applications.....II-61
Healthcare.....II-61
1$100
   Select Marine Diterpenes and Their Biological Activity.....II-62
Select Players Involved in Biosensor/Diagnostic Activity.....II-62
Bioprospecting.....II-62
1$100
   Select Companies Involved in Bioprospecting and Bioscreening for Novel Marine- Based
  Compounds.....II-63
Consumer Products.....II-63
Select Macroalgal Materials and Applications in Cosmetic Industry.....II-63
Public Services and Infrastructure.....II-63
1$100
   Others.....II-64
An Insight into Select Marine-Origin Products.....II-64
Agar.....II-64
Major Seaweeds Used for Extracting Agar and Agarose.....II-64
1$100
   Alginate.....II-65
Astaxanthin.....II-65
1$100
   Select Producers of Natural and Synthetic Astaxanthin.....II-66
Carrageenan.....II-66
1$100
   Chitin and Chitosan.....II-67
Chitin.....II-67
Chitosan.....II-67
Select Industrial Applications of Chitosan.....II-67
1$100
   Collagen.....II-68
Salmon Calcitonin.....II-68
1$100
   New Research Finding Reveals the Role of Opisthobranchs in Lignarenones
  Biosynthesis.....II-69
Norwegian Researchers Explore Potential of Tunicate as a Source of Biofuel and Fish
  Feed.....II-69
1$100
   Scientists Unearth Medicinal Properties of Marine Enzyme, Bacillus
  Licheniformis.....II-70
Norwegian Researchers Study Potential of Farmed Salmon Waste as Nutrients to Nourish
  Kelp and Mussel.....II-70
Researchers Study Effectiveness of Alginate Supplementation on Weight Loss.....II-70
1$100
   Lamellarins Can Stop Cancer Drug Resistance: New Finding on Marine Natural
  Product.....II-71
Evaluation of DHA and EPA Concentration in Algal Species.....II-71
1$100
   Study of Potential Applications of Delesseria Sanguinea.....II-72
Scientists Use Bacteria Occurring in Marine Waters to Develop New Assays.....II-72
1$100
   Bluewave Marine Ingredients Launches AminoMarine™ Fish Protein Powder.....II-73
Cyvex Nutrition Rolls Out Protomine™ Fish Protein Powder.....II-73
Lipotec Unveils Seacode Marine-based Anti-Ageing Ingredient.....II-73
Marie Veronique Organics Rolls Out Pacific Line of Anti-Aging Products.....II-73
1$100
   DSM Unveils DHA plus EPA™ Product.....II-74
Aqua Bio Technology Launches New Marine-Based Ingredients.....II-74
La Prairie Launches Lifestyle Collection.....II-74
1$100
   Aqua Bio Technology Launches Zonase X Marine Ingredient.....II-75
Frutarom USA to Introduce New Range of Marine Extracts.....II-75
1$100
   Biotech Marine Launches BioFA Anti-Aging Ingredient.....II-761$100
   FMC Snaps Up Epax.....II-77
Seppic Takes Over BiotechMarine.....II-77
Aker BioMarine Inks Agreement with BioMar Group.....II-77
1$100
   NPC Inks Agreement with BASF.....II-78
Olympic Seafood Enters into Long-Term Licensing Agreement with Aker BioMarine.....II-78
PharmaMar Teams with Costa Rican Experts.....II-78
1$100
   Aqua Bio Technology Clinches Two Sales Contracts from a Cosmetics Company.....II-79
PharmaMar Demonstrates New Clinical Trials with Four Marine-Derived Anti-Tumor
  Drugs.....II-79
Stemtech International Inks Agreement with Marinova.....II-79
1$100
   ABT Bags Multi Million Contract from Restorsea for Aquabeautine XL™ Ingredient.....II-80
Aquapharm Collaborates with c-LEcta.....II-80
Aquapharm Joins Forces with Australian Institute of Marine Science.....II-80
Aqua Bio Technology Signs Agreement with Amway.....II-80
1$100
   Aquapharm Enters into Partnership with Aqua Bio Technology.....II-81
AE Biofuels Renames as Aemetis.....II-81
Jazz Pharmaceuticals Takes Over Azur Pharma.....II-81
DSM Acquires Martek.....II-81
1$100
   Ashland Acquires ISP.....II-82
Aquapharm Strikes Agreement with Sederma.....II-82
Seattle Genetics Receives FDA Approval for Adcetris.....II-82
1$100
   New England Biolabs Establishes New England Biolabs France.....II-83
Eisai Obtains FDA Clearance for Halaven, a Marine-Derived Breast Cancer Drug.....II-83
Azur Pharma Acquires PRIALT® from Elan Pharmaceuticals.....II-83
Aqua Bio Technology Inks Supply Agreement with Bioforskning.....II-83
1$100
   Aquapharm Biodiscovery Signs Licensing and Collaboration Agreement with Croda.....II-84
AsiaPharm and GlycoMar Sign R&D Agreement.....II-84
Aquatic Eco-Systems Acquires Marine Biotech.....II-84
Dr. Reddy's Laboratories and Aquapharm Biodiscovery Ink Licensing Agreements.....II-84
Aker BioMarine Merges with Natural ASA to Form Aker BioMarine.....II-84
1$100
   Aker BioMarine Joins Hands with Pronova Biocare.....II-85
ABL Biotech to Establish New R&D Facility.....II-85
Aquapharm Strikes an Agreement with DowpharmaSM.....II-85
MMRC and Nereus Pharmaceuticals to Initiate Clinical Trials for NPI-0052.....II-85
CP Kelco Acquires Gold Millet.....II-85
Oman’s Attempt To Excel in Marine Research.....II-85
1$100
   Marical Inks an Agreement with ACD.....II-86
PharmaMar Conducts Clinical Testing of Zalypsis ® Anti-tumor Agent.....II-86
CP Kelco Merges with Noviant.....II-86
Marine Institute, Biotrove, and NUI’S Cooperative Research on Atlantic Salmon.....II-86
Jinghua Marine Biological Merges with Work Recovery.....II-86
1$100
   Albany Molecular Research and Alcon Research in Partnership.....II-87
Maryland-Israel Marine Biotechnology Research Program Gains Extension.....II-87
India to Set Up New National Institutions.....II-87
European Centre for Marine Biotechnology Inaugurated.....II-87
Diversa Collaborates with OSU.....II-87
1$100
   PharmaMar Commences Phase I Clinical Trials of PM02734.....II-88
USFDA Confers Orphan Drug Status to PharmaMar’s Ovarian Cancer Drug, YONDELIS®.....II-88
PharmaMar Undertakes Phase II Clinical Trials of Aplidin® for Bladder and Prostate
  Cancers.....II-88
CorMatrix and Cook Biotech Enter into Research Agreement.....II-88
Elan Corp Receives European Approval for PRIALT™ (Ziconotide).....II-88
1$100
   Aker BioMarine AS (Norway).....II-89
Aqua Bio Technology ASA (Norway).....II-89
Aquapharm Biodiscovery Ltd (UK).....II-89
CP Kelco (US).....II-89
1$100
   Cyanotech Corp. (US).....II-90
Nutrex Hawaii (US).....II-90
FMC Corp. (US).....II-90
1$100
   FMC BioPolymer (US).....II-91
NovaMatrix (Norway).....II-91
GlycoMar Ltd. (UK).....II-91
Jazz Pharmaceuticals plc (Ireland).....II-91
1$100
   Lonza Group Ltd (Switzerland).....II-92
Marinova Pty Ltd (Australia).....II-92
1$100
   New England Biolabs Inc (US).....II-93
oceanBASIS GmbH (Germany).....II-93
PharmaMar S.A (Spain).....II-93
PML Applications Ltd. (UK).....II-93
1$100
   Prolume Ltd (US).....II-94
BioLume®, Inc. (US).....II-94
Pronova BioPharma ASA (Norway).....II-94
1$100
   Royal DSM N.V (Netherlands).....II-95
Sea Run Holdings, Inc. (US).....II-95
1$100
   SEPPIC (France).....II-96
Biotech Marine (France).....II-96
Tequesta BioVentures (US).....II-96
1$100
   Table 4: World Recent Past, Current & Future Analysis for Marine Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-971$350
   Table 5: World Historic Review for Marine Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-981$350
   Table 6: World 15-Year Perspective for Marine Biotechnology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart).....II-991$350
   Table 7: World Recent Past, Current & Future Analysis for Marine Biotechnology by Product Segment - Marine Biomaterials, Marine Bioactive Substances, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-1001$350
   Table 8: World Historic Review for Marine Biotechnology by Product Segment - Marine Biomaterials, Marine Bioactive Substances, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-1011$350
   Table 9: World 15-Year Perspective for Marine Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Marine Biomaterials, Marine Bioactive Substances, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart).....II-1021$350
   Table 10: World Recent Past, Current & Future Analysis for Marine Biotechnology by End-Use Application - Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services and Infrastructure and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-1031$350
   Table 11: World Historic Review for Marine Biotechnology by End-Use Application - Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services and Infrastructure and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-1041$350
   Table 12: World 15-Year Perspective for Marine Biotechnology by End-Use Application - Percentage Breakdown of Dollar Sales for Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services and Infrastructure and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart).....II-1051$350
   A. Market Analysis.....III-1
Overview.....III-1
Aquaculture Biotechnology.....III-1
Policy Framework to Offer Support for Marine Biotechnology.....III-1
1$75
   Product Launches.....III-21$75
   Strategic Corporate Developments.....III-32$150
   Key Players.....III-53$225
   B. Market Analytics.....III-8
Table 13: US Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-8
1$200
   Table 14: US Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-91$200
   Market Analysis.....III-10
Table 15: Canadian Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-10
1$200
   Table 16: Canadian Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-111$200
   Market Analysis.....III-12
Table 17: Japanese Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-12
1$200
   Table 18: Japanese Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-131$200
   A. Market Analysis.....III-14
Marine Biotechnology: Promising Opportunities for Europe.....III-14
A Nascent Yet Promising Market.....III-14
1$75
   Marine and Algae Oils Market in Europe: An Overview.....III-15
Prospects for Blue Technology in Baltic Sea Region.....III-15
1$75
   A Distinct Identity for Marine Biotechnology: The Way Forward.....III-16
Marine Drug Discovery: Need for Diversifying Research Focus.....III-16
Regulations Governing Marine Biotechnology in Europe.....III-16
2$150
   A Glance at Key Documents & Events Focused on Marine Biotechnology.....III-18
Initiatives for Marine Biotechnology Growth.....III-18
2$150
   The European Commission Policies on Blue Technology (Marine and Freshwater
  Biotechnology).....III-20
Horizon 2020: Aiming for Faster Marketability of Innovations.....III-20
Focus on Select Regional Markets.....III-20
Belgium.....III-20
1$75
   Denmark.....III-21
Germany.....III-21
North Germany Focuses on Maritime Resources.....III-21
Ireland.....III-21
1$75
   Norway.....III-22
Overview.....III-22
Norway Leads in Bioprospecting Arctic Genetic Resources in Nordic
  Countries.....III-22
1$75
   Market Participants.....III-23
Industrial Applications.....III-23
Pharmaceuticals.....III-23
Norwegian Marine Biotechnology Companies.....III-23
2$150
   Iceland.....III-25
Spain.....III-25
The United Kingdom.....III-25
Overview.....III-25
1$75
   Role of Marine Algal Biomass in Energy Sector in UK.....III-26
Product Innovations/Introductions.....III-26
2$150
   Strategic Corporate Developments.....III-284$300
   Key Players.....III-325$375
   B. Market Analytics.....III-37
Table 19: European Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-37
1$200
   Table 20: European Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-381$200
   A. Market Analysis.....III-39
Outlook.....III-39
Australia.....III-39
China.....III-39
1$75
   India.....III-40
Marine Environment Offers Abundant Opportunities for R&D Initiatives.....III-40
Biotechnology Market in India on a Growth Trajectory.....III-40
1$75
   Government Initiatives.....III-41
New Zealand.....III-41
South Korea.....III-41
1$75
   Strategic Corporate Developments.....III-421$75
   Marinova Pty Ltd (Australia) – A Key Player.....III-43
B. Market Analytics.....III-43
Table 21: Asia-Pacific Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-43
1$200
   Table 22: Asia-Pacific Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-441$200
   A. Market Analysis.....III-45
Outlook.....III-45
Latin America.....III-45
Strategic Corporate Developments.....III-45
1$75
   B. Market Analytics.....III-46
Table 23: Rest of World Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-46
1$200
   Table 24: Rest of World Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-471$200
  
Total Companies Profiled: 99 (including Divisions/Subsidiaries - 108)

Region/Country Players

The United States 29 Canada 3 Japan 2 Europe 54 France 4 Germany 4 The United Kingdom 5 Spain 2 Rest of Europe 39 Asia-Pacific (Excluding Japan) 17 Latin America 1 Middle East 2
Click here to request a full table of contents and more details on this project.